Copyright Reports & Markets. All rights reserved.

Global and Japan Hospital Acquired Infections (HAI) Diagnostics Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Molecular Diagnostics Tests
    • 1.2.3 Other In-vitro Diagnostic Tests
  • 1.3 Market by Application
    • 1.3.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Application: 2020 VS 2026
    • 1.3.2 Bloodstream Infections (BSI)
    • 1.3.3 Urinary Tract Infections (UTI)
    • 1.3.4 Surgical Site Infections (SSI)
    • 1.3.5 Pneumonia
    • 1.3.6 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Perspective (2015-2026)
  • 2.2 Global Hospital Acquired Infections (HAI) Diagnostics Growth Trends by Regions
    • 2.2.1 Hospital Acquired Infections (HAI) Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Hospital Acquired Infections (HAI) Diagnostics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Market Size
    • 3.1.1 Global Top Hospital Acquired Infections (HAI) Diagnostics Players by Revenue (2015-2020)
    • 3.1.2 Global Hospital Acquired Infections (HAI) Diagnostics Revenue Market Share by Players (2015-2020)
  • 3.2 Global Hospital Acquired Infections (HAI) Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Hospital Acquired Infections (HAI) Diagnostics Revenue
  • 3.4 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio
    • 3.4.1 Global Hospital Acquired Infections (HAI) Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infections (HAI) Diagnostics Revenue in 2019
  • 3.5 Key Players Hospital Acquired Infections (HAI) Diagnostics Area Served
  • 3.6 Key Players Hospital Acquired Infections (HAI) Diagnostics Product Solution and Service
  • 3.7 Date of Enter into Hospital Acquired Infections (HAI) Diagnostics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Type (2015-2026)

  • 4.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Type (2015-2020)
  • 4.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Type (2021-2026)

5 Hospital Acquired Infections (HAI) Diagnostics Breakdown Data by Application (2015-2026)

  • 5.1 Global Hospital Acquired Infections (HAI) Diagnostics Historic Market Size by Application (2015-2020)
  • 5.2 Global Hospital Acquired Infections (HAI) Diagnostics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2026)
  • 6.2 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
  • 6.3 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
  • 6.4 North America Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2026)
  • 7.2 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
  • 7.3 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
  • 7.4 Europe Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2026)
  • 8.2 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
  • 8.3 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
  • 8.4 China Hospital Acquired Infections (HAI) Diagnostics Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2026)
  • 9.2 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
  • 9.3 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
  • 9.4 Japan Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size (2015-2026)
  • 10.2 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Hospital Acquired Infections (HAI) Diagnostics Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 BioMérieux
    • 11.1.1 BioMérieux Company Details
    • 11.1.2 BioMérieux Business Overview
    • 11.1.3 BioMérieux Hospital Acquired Infections (HAI) Diagnostics Introduction
    • 11.1.4 BioMérieux Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020))
    • 11.1.5 BioMérieux Recent Development
  • 11.2 Abbott Laboratories
    • 11.2.1 Abbott Laboratories Company Details
    • 11.2.2 Abbott Laboratories Business Overview
    • 11.2.3 Abbott Laboratories Hospital Acquired Infections (HAI) Diagnostics Introduction
    • 11.2.4 Abbott Laboratories Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
    • 11.2.5 Abbott Laboratories Recent Development
  • 11.3 Roche AG
    • 11.3.1 Roche AG Company Details
    • 11.3.2 Roche AG Business Overview
    • 11.3.3 Roche AG Hospital Acquired Infections (HAI) Diagnostics Introduction
    • 11.3.4 Roche AG Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
    • 11.3.5 Roche AG Recent Development
  • 11.4 Siemens Healthcare
    • 11.4.1 Siemens Healthcare Company Details
    • 11.4.2 Siemens Healthcare Business Overview
    • 11.4.3 Siemens Healthcare Hospital Acquired Infections (HAI) Diagnostics Introduction
    • 11.4.4 Siemens Healthcare Revenue in Hospital Acquired Infections (HAI) Diagnostics Business (2015-2020)
    • 11.4.5 Siemens Healthcare Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Hospital Acquired Infections (HAI) Diagnostics Scope and Market Size
    Hospital Acquired Infections (HAI) Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infections (HAI) Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Molecular Diagnostics Tests
    Other In-vitro Diagnostic Tests

    Market segment by Application, split into
    Bloodstream Infections (BSI)
    Urinary Tract Infections (UTI)
    Surgical Site Infections (SSI)
    Pneumonia
    Others

    Based on regional and country-level analysis, the Hospital Acquired Infections (HAI) Diagnostics market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Hospital Acquired Infections (HAI) Diagnostics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    BioMérieux
    Abbott Laboratories
    Roche AG
    Siemens Healthcare
    ...

    Buy now